S. Oertelt-Prigione, Netherlands

University of Radbout Department of Primary and Community Care
Sabine Oertelt-Prigione MD, PhD, MScPH has been working in the field of sex and gender-sensitive research for the last 15 years. After her medical studies, she investigated the biological basis of sex differences in autoimmunity. She then focused on the role of sex and gender in cardiovascular diseases. Realizing that the implementation of sex and gender-sensitive medicine is a change process that affects organizations as much as researchers, she obtained training as an organizational consultant. With these tools she is now trying to understand how sex and gender-sensitive medicine can be successfully implemented. Her work focuses on the entire implementation arch: What is the status quo in sex and gender-sensitive research? What should be done? What is practically feasible in an everyday clinical and research context? And, finally, how to we institutionalize these practices? She has developed the first international database about sex and gender-specific research, co-editor of one of the first textbooks in the discipline and has conducted the largest study in Europe on gendered harassment in academia. She worked with the EU Commission in the EU expert group “Gendered Innovations”, consults with national governments and funding agencies and advises startups that want to focus on sex and gender-sensitive topics.

Presenter of 2 Presentations

Workshop: The Impact of the COVID-19 Pandemic on Women’s Mental Health and Service Delivery: What Have we Learnt? (ID 200) No Topic Needed
Workshop: The Impact of the COVID-19 Pandemic on Women’s Mental Health and Service Delivery: What Have we Learnt? (ID 200) No Topic Needed

W0034 - The Impact of Gender in the COVID-19 Pandemic

Session Icon
Pre-Recorded with Live Q&A, Section
Mon, 12.04.2021
Session Time
10:00 - 11:30
Channel 5
Lecture Time
10:00 - 10:14


Abstract Body

Data worldwide is pointing towards an increased mortality of men a from COVID-19, while infection rates are equal or higher in women. Immunological differences might play a role in this as well as differences in risk factors and co-morbidities. In addition, differences in exposure, testing, case definitions and access to healthcare might play a role. Differences in symptoms have been reported, as well as potential differences in therapeutic choices. Also, the phenomenon of “long COVID” with all its psychophysical consequences appears to be more common in women. In addition to the consequences of the acute infection, COVID-19 is significantly impacting economies, social systems and political priorities.

I will try to give a general overview of the current situation, starting from a medical standpoint and moving into the wider social consequences of this pandemic. I will highlight how the lack of attention to sex and gender can impact statistics, potential therapies and vaccines, livelihoods and the healthcare sector as a whole.